Event | Nov 16-18, 2022
European Bioanalysis Forum
European Bioanalysis Forum (EBF) was founded in 2006 at the initiative of 12 pharmaceutical companies. The goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to pharmaceutical research and development companies with bioanalytical activities in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in Europe. Since 2010, the EBF became a non-profit organisation (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations. Currently, the EBF counts 75 members (June 2022).
As usual, EBF will be in Barcelona, Spain this year.
The crucial role of BioAnalysis for the successful implementation of pre-clinical and subsequent clinical pharmacological studies means BioAnalytical teams are under pressure to increase throughput, without compromising quality and data integrity.
Visit us at booth tbd to discover how our secure, compliant Polar BioAnalysis data management platform could transform your bioanalytical operations and increase capacity by driving quality, consistency and cutting your study cycle time by up to 50%.
Polar BioAnalysis combines electronic data capture with structured workflows that drive standard bioanalytical processes. We’ve based these workflows on best practices defined with the world’s leading pharmaceutical, biotech and CROs, and configured them for study definition, sample preparation, data acquisition and analysis, and workflow auditing.
We look forward to seeing you at EBF!
Meet the team
Ajaz Rosul, Lead Solutions Consultant